High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome

Pellicer, 1987, Outcome of in vitro fertilization in women with low re¬sponse to ovarian stimulation, Fertil Steril, 47, 812, 10.1016/S0015-0282(16)59170-5

Toner, 1991, Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age, Fertil Steril, 55, 784, 10.1016/S0015-0282(16)54249-6

Ben-Rafael, 1986, Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation, Fertil Steril, 46, 586, 10.1016/S0015-0282(16)49632-9

Jenkins, 1991, Comparison of “poor” responders with “good” responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization, Hum Reprod, 6, 918, 10.1093/oxfordjournals.humrep.a137459

Stadtmauer, 1994, High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer, Fertil Steril, 61, 1058, 10.1016/S0015-0282(16)56756-9

Ben-Rafael, 1987, Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program, Fertil Steril, 48, 964, 10.1016/S0015-0282(16)59592-2

Daya, 1995, Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization: results of a meta-analysis, Horm Res, 43, 224, 10.1159/000184283

Simon, 1995, High doses of gonadotropins have no detrimental effect on in vitro fertilization outcome in normal responders, Fertil Steril, 63, 1333, 10.1016/S0015-0282(16)57621-3